GPRC5D CAR-T cell intravenous infusion
XBAP2025-9
Phase 1 mab active
Quick answer
GPRC5D CAR-T cell intravenous infusion for Plasma Cell Dyscrasias is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Plasma Cell Dyscrasias
- Phase
- Phase 1
- Modality
- mab
- Status
- active